Studies indicate that metabolic disorders are a significant cause of cardiovascular diseases, and FNIP1 may act as a key regulator in these disorders, playing a crucial role in the pathogenesis of cardiovascular conditions (Hong et al., 2018; Zhang H. et al., 2023). This evidence concerns the gene FNIP1 and metabolic disease.